Genfit

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Genfit and buy or sell other stocks, ETFs, and their options commission-free!

About GNFTY

Genfit SA is a biopharmaceutical company involved in drug discovery and development for the early diagnosis, prevention and treatment of cardiometabolic diseases. The company focuses on the discovery and development of drug candidates in areas of high unmet medical needs corresponding to a lack of suitable treatments. 

CEO
Pascal Prigent
CEOPascal Prigent
Employees
180
Employees180
Headquarters
Loos, Hauts-de-France
HeadquartersLoos, Hauts-de-France
Founded
1999
Founded1999
Employees
180
Employees180

GNFTY Key Statistics

Market cap
430.25M
Market cap430.25M
Price-Earnings ratio
-10.18
Price-Earnings ratio-10.18
Dividend yield
Dividend yield
Average volume
3.96K
Average volume3.96K
High today
$9.39
High today$9.39
Low today
$8.55
Low today$8.55
Open price
$9.10
Open price$9.10
Volume
15.04K
Volume15.04K
52 Week high
$10.20
52 Week high$10.20
52 Week low
$2.55
52 Week low$2.55

Analyst ratings

83%

of 6 ratings
Buy
83.3%
Hold
16.7%
Sell
0%

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.